Sinsuat, Mariam .
HRN: 10-08-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/18/2025
11/25/2025
IV
2.25G
Q8H
Pneumonia
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines